{"transactions":[{"id":800991,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-25T00:41:26.000Z","date":"2026-04-23","kind":"exercise","planned":true,"acquired":false,"shares":12941,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025."}],"balance_after":150000,"derivative":{"exercise_price":16.45,"expiration_date":"2034-11-04","underlying":"Common Stock","underlying_shares":12941},"source":{"system":"sec-edgar","filing":"0001628280-26-027287","document":"wk-form4_1777077683.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1734779/000162828026027287/wk-form4_1777077683.xml","form_type":"4"}},{"id":800990,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-25T00:41:26.000Z","date":"2026-04-23","kind":"sale","planned":true,"acquired":false,"shares":12941,"price":25.16,"value":325595.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.41, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":105341,"source":{"system":"sec-edgar","filing":"0001628280-26-027287","document":"wk-form4_1777077683.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1734779/000162828026027287/wk-form4_1777077683.xml","form_type":"4"}},{"id":800989,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-25T00:41:26.000Z","date":"2026-04-23","kind":"exercise","planned":true,"acquired":true,"shares":12941,"price":16.45,"value":212879.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025."}],"balance_after":118282,"source":{"system":"sec-edgar","filing":"0001628280-26-027287","document":"wk-form4_1777077683.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734779/000162828026027287/wk-form4_1777077683.xml","form_type":"4"}},{"id":802916,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-23T00:03:15.000Z","date":"2026-04-22","kind":"exercise","planned":true,"acquired":false,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025."}],"balance_after":162941,"derivative":{"exercise_price":16.45,"expiration_date":"2034-11-04","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001628280-26-026669","document":"wk-form4_1776902593.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1734779/000162828026026669/wk-form4_1776902593.xml","form_type":"4"}},{"id":802915,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-23T00:03:15.000Z","date":"2026-04-21","kind":"exercise","planned":true,"acquired":false,"shares":2845,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025."}],"balance_after":164441,"derivative":{"exercise_price":16.45,"expiration_date":"2034-11-04","underlying":"Common Stock","underlying_shares":2845},"source":{"system":"sec-edgar","filing":"0001628280-26-026669","document":"wk-form4_1776902593.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1734779/000162828026026669/wk-form4_1776902593.xml","form_type":"4"}},{"id":802914,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-23T00:03:15.000Z","date":"2026-04-20","kind":"exercise","planned":true,"acquired":false,"shares":7714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025."}],"balance_after":167286,"derivative":{"exercise_price":16.45,"expiration_date":"2034-11-04","underlying":"Common Stock","underlying_shares":7714},"source":{"system":"sec-edgar","filing":"0001628280-26-026669","document":"wk-form4_1776902593.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1734779/000162828026026669/wk-form4_1776902593.xml","form_type":"4"}},{"id":802913,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-23T00:03:15.000Z","date":"2026-04-22","kind":"sale","planned":true,"acquired":false,"shares":1500,"price":25.01,"value":37515.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.04, inclusive."}],"balance_after":105341,"source":{"system":"sec-edgar","filing":"0001628280-26-026669","document":"wk-form4_1776902593.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1734779/000162828026026669/wk-form4_1776902593.xml","form_type":"4"}},{"id":802912,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-23T00:03:15.000Z","date":"2026-04-22","kind":"exercise","planned":true,"acquired":true,"shares":1500,"price":16.45,"value":24675.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025."}],"balance_after":106841,"source":{"system":"sec-edgar","filing":"0001628280-26-026669","document":"wk-form4_1776902593.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1734779/000162828026026669/wk-form4_1776902593.xml","form_type":"4"}},{"id":802911,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-23T00:03:15.000Z","date":"2026-04-21","kind":"sale","planned":true,"acquired":false,"shares":2845,"price":25.01,"value":71153.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.04, inclusive."}],"balance_after":105341,"source":{"system":"sec-edgar","filing":"0001628280-26-026669","document":"wk-form4_1776902593.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1734779/000162828026026669/wk-form4_1776902593.xml","form_type":"4"}},{"id":802910,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-23T00:03:15.000Z","date":"2026-04-21","kind":"exercise","planned":true,"acquired":true,"shares":2845,"price":16.45,"value":46800.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025."}],"balance_after":108186,"source":{"system":"sec-edgar","filing":"0001628280-26-026669","document":"wk-form4_1776902593.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1734779/000162828026026669/wk-form4_1776902593.xml","form_type":"4"}},{"id":802909,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-23T00:03:15.000Z","date":"2026-04-20","kind":"sale","planned":true,"acquired":false,"shares":7714,"price":25.14,"value":193929.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.31, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 2 and 3."}],"balance_after":105341,"source":{"system":"sec-edgar","filing":"0001628280-26-026669","document":"wk-form4_1776902593.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1734779/000162828026026669/wk-form4_1776902593.xml","form_type":"4"}},{"id":802908,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-23T00:03:15.000Z","date":"2026-04-20","kind":"exercise","planned":true,"acquired":true,"shares":7714,"price":16.45,"value":126895.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025."}],"balance_after":113055,"source":{"system":"sec-edgar","filing":"0001628280-26-026669","document":"wk-form4_1776902593.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734779/000162828026026669/wk-form4_1776902593.xml","form_type":"4"}},{"id":905279,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-13T21:02:23.000Z","date":"2026-02-11","kind":"grant","planned":false,"acquired":true,"shares":49091,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning on February 15, 2027, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":105341,"source":{"system":"sec-edgar","filing":"0001628280-26-008080","document":"wk-form4_1771016540.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734779/000162828026008080/wk-form4_1771016540.xml","form_type":"4"}},{"id":972697,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-12T02:47:00.000Z","date":"2025-12-10","kind":"exercise","planned":true,"acquired":false,"shares":9104,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":175000,"derivative":{"exercise_price":16.45,"expiration_date":"2034-11-04","underlying":"Common Stock","underlying_shares":9104},"source":{"system":"sec-edgar","filing":"0001628280-25-056645","document":"wk-form4_1765507617.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1734779/000162828025056645/wk-form4_1765507617.xml","form_type":"4"}},{"id":972696,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-12T02:47:00.000Z","date":"2025-12-09","kind":"exercise","planned":true,"acquired":false,"shares":15896,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":184104,"derivative":{"exercise_price":16.45,"expiration_date":"2034-11-04","underlying":"Common Stock","underlying_shares":15896},"source":{"system":"sec-edgar","filing":"0001628280-25-056645","document":"wk-form4_1765507617.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1734779/000162828025056645/wk-form4_1765507617.xml","form_type":"4"}},{"id":972695,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-12T02:47:00.000Z","date":"2025-12-10","kind":"sale","planned":true,"acquired":false,"shares":9104,"price":25.14,"value":228874.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.30, inclusive."}],"balance_after":56250,"source":{"system":"sec-edgar","filing":"0001628280-25-056645","document":"wk-form4_1765507617.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1734779/000162828025056645/wk-form4_1765507617.xml","form_type":"4"}},{"id":972694,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-12T02:47:00.000Z","date":"2025-12-10","kind":"exercise","planned":true,"acquired":true,"shares":9104,"price":16.45,"value":149760.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":65354,"source":{"system":"sec-edgar","filing":"0001628280-25-056645","document":"wk-form4_1765507617.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1734779/000162828025056645/wk-form4_1765507617.xml","form_type":"4"}},{"id":972693,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-12T02:47:00.000Z","date":"2025-12-09","kind":"sale","planned":true,"acquired":false,"shares":15896,"price":25.03,"value":397876.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.11, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 2 and 3."}],"balance_after":56250,"source":{"system":"sec-edgar","filing":"0001628280-25-056645","document":"wk-form4_1765507617.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1734779/000162828025056645/wk-form4_1765507617.xml","form_type":"4"}},{"id":972692,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-12T02:47:00.000Z","date":"2025-12-09","kind":"exercise","planned":true,"acquired":true,"shares":15896,"price":16.45,"value":261489.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":72146,"source":{"system":"sec-edgar","filing":"0001628280-25-056645","document":"wk-form4_1765507617.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734779/000162828025056645/wk-form4_1765507617.xml","form_type":"4"}},{"id":1000295,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-13T21:13:23.000Z","date":"2025-11-10","kind":"sale","planned":true,"acquired":false,"shares":12060,"price":22.09,"value":266405.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":56250,"source":{"system":"sec-edgar","filing":"0001628280-25-052038","document":"wk-form4_1763068400.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734779/000162828025052038/wk-form4_1763068400.xml","form_type":"4"}},{"id":1009634,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-03T22:41:34.000Z","date":"2025-10-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":6690,"price":21.38,"value":143032.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the issuer to cover tax obligations upon the vesting of restricted stock units."}],"balance_after":68310,"source":{"system":"sec-edgar","filing":"0001628280-25-048393","document":"wk-form4_1762209691.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734779/000162828025048393/wk-form4_1762209691.xml","form_type":"4"}},{"id":1237029,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-03-03T11:44:36.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":28597,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the issuer's non-employee director compensation policy. Grant reflects director compensation for the fourth quarter of 2024 and from January 1, 2025 through March 25, 2025. The number of shares received in lieu of cash was calculated based on the closing price of $0.77 per share of common stock on February 26, 2025."}],"balance_after":136346,"source":{"system":"sec-edgar","filing":"0001437749-25-005850","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774925005850/rdgdoc.xml","form_type":"4"}},{"id":1362567,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-11-18T14:10:53.000Z","date":"2024-11-15","kind":"grant","planned":false,"acquired":true,"shares":17228,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the issuer's non-employee director compensation policy. Grant reflects director compensation for the third quarter of 2024. The number of shares received in lieu of cash was calculated based on the closing price of $0.66 per share of common stock on November 14, 2024"}],"balance_after":107749,"source":{"system":"sec-edgar","filing":"0001437749-24-035588","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774924035588/rdgdoc.xml","form_type":"4"}},{"id":1375540,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-05T21:42:18.000Z","date":"2024-11-04","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":200000,"derivative":{"exercise_price":16.45,"expiration_date":"2034-11-04","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001396814-24-000135","document":"wk-form4_1730842931.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1734779/000139681424000135/wk-form4_1730842931.xml","form_type":"4"}},{"id":1375539,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-11-05T21:42:18.000Z","date":"2024-11-01","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning on November 1, 2025, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":75000,"source":{"system":"sec-edgar","filing":"0001396814-24-000135","document":"wk-form4_1730842931.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734779/000139681424000135/wk-form4_1730842931.xml","form_type":"4"}},{"id":1428252,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-08-20T13:49:08.000Z","date":"2024-08-16","kind":"grant","planned":false,"acquired":true,"shares":9028,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the issuer's non-employee director compensation policy. Grant reflects director compensation for the second quarter of 2024. The number of shares received in lieu of cash was calculated based on the closing price of $1.26 per share of common stock on August 16, 2024."}],"balance_after":90521,"source":{"system":"sec-edgar","filing":"0001437749-24-027329","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774924027329/rdgdoc.xml","form_type":"4"}},{"id":1490815,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-05T17:09:05.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":15562,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests over a one year period in equal quarterly installments."}],"balance_after":15562,"derivative":{"exercise_price":1.28,"expiration_date":"2034-06-03","underlying":"Common Stock","underlying_shares":15562},"source":{"system":"sec-edgar","filing":"0001437749-24-019344","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774924019344/rdgdoc.xml","form_type":"4"}},{"id":1490814,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-05T17:09:05.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":8887,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the issuer's non-employee director compensation policy. Grant reflects director compensation for the first quarter of 2024. The number of shares received in lieu of cash was calculated based on the closing price of $1.28 per share of common stock on June 3, 2024."}],"balance_after":81493,"source":{"system":"sec-edgar","filing":"0001437749-24-019344","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774924019344/rdgdoc.xml","form_type":"4"}},{"id":1699026,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":true}}],"security":"Stock Option (Right to buy)","published_at":"2023-12-28T21:50:39.000Z","date":"2023-12-27","kind":"grant","planned":false,"acquired":true,"shares":88910,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 21, 2023, Cyclo Therapeutics, Inc. (\"Cyclo\"), Cameo Merger Sub, Inc. (\"Merger Sub\"), and Applied Molecular Transport, Inc. (\"AMTI\") entered into an Agreement and Plan of Merger (the \"Merger Agreement\"), pursuant to which, among other matters, and subject to the satisfaction or waiver of the conditions set forth in the Merger Agreement, Merger Sub will merge with and into AMTI, with AMTI continuing as a wholly owned subsidiary of Cyclo and the surviving corporation of the merger (the \"Merger\"). Upon the effective time of the Merger on December 27, 2023, the Reporting Person received shares of Cyclo common stock in exchange for shares of AMTI common stock and options to acquire shares of Cyclo common stock in exchange for options to acquire shares of AMTI common stock, each based on the exchange ratio determined by the Merger Agreement. All AMTI restricted stock units held by the Reporting Person were fully settled prior to the effective time of the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options were fully vested upon the closing of the Merger Agreement."}],"balance_after":89910,"derivative":{"exercise_price":2.96,"exercise_date":"2023-12-27","expiration_date":"2024-12-27","underlying":"Common Stock","underlying_shares":88910},"source":{"system":"sec-edgar","filing":"0001437749-23-035527","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774923035527/rdgdoc.xml","form_type":"4"}},{"id":1699025,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-12-28T21:50:39.000Z","date":"2023-12-27","kind":"grant","planned":false,"acquired":true,"shares":72606,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 21, 2023, Cyclo Therapeutics, Inc. (\"Cyclo\"), Cameo Merger Sub, Inc. (\"Merger Sub\"), and Applied Molecular Transport, Inc. (\"AMTI\") entered into an Agreement and Plan of Merger (the \"Merger Agreement\"), pursuant to which, among other matters, and subject to the satisfaction or waiver of the conditions set forth in the Merger Agreement, Merger Sub will merge with and into AMTI, with AMTI continuing as a wholly owned subsidiary of Cyclo and the surviving corporation of the merger (the \"Merger\"). Upon the effective time of the Merger on December 27, 2023, the Reporting Person received shares of Cyclo common stock in exchange for shares of AMTI common stock and options to acquire shares of Cyclo common stock in exchange for options to acquire shares of AMTI common stock, each based on the exchange ratio determined by the Merger Agreement. All AMTI restricted stock units held by the Reporting Person were fully settled prior to the effective time of the Merger."}],"balance_after":72606,"source":{"system":"sec-edgar","filing":"0001437749-23-035527","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774923035527/rdgdoc.xml","form_type":"4"}},{"id":1698748,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & Chair of the Board"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-28T17:29:59.000Z","date":"2023-12-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":668000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, this option was exchanged for an option covering 88,910 shares of Cyclo Common Stock."}],"balance_after":0,"derivative":{"exercise_price":0.3936,"expiration_date":"2033-03-24","underlying":"Common Stock","underlying_shares":668000},"source":{"system":"sec-edgar","filing":"0001209191-23-059929","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919123059929/doc4.xml","form_type":"4"}},{"id":1698747,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & Chair of the Board"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-28T17:29:59.000Z","date":"2023-12-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":84000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the effective time of the merger, each outstanding option with an exercise price of $0.40 or more was cancelled effective as of the closing."}],"balance_after":0,"derivative":{"exercise_price":3.99,"expiration_date":"2032-05-16","underlying":"Common Stock","underlying_shares":84000},"source":{"system":"sec-edgar","filing":"0001209191-23-059929","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919123059929/doc4.xml","form_type":"4"}},{"id":1698746,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & Chair of the Board"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-28T17:29:59.000Z","date":"2023-12-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":94500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the effective time of the merger, each outstanding option with an exercise price of $0.40 or more was cancelled effective as of the closing."}],"balance_after":0,"derivative":{"exercise_price":8.29,"expiration_date":"2032-02-15","underlying":"Common Stock","underlying_shares":94500},"source":{"system":"sec-edgar","filing":"0001209191-23-059929","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919123059929/doc4.xml","form_type":"4"}},{"id":1698745,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & Chair of the Board"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-28T17:29:59.000Z","date":"2023-12-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":63000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the effective time of the merger, each outstanding option with an exercise price of $0.40 or more was cancelled effective as of the closing."}],"balance_after":0,"derivative":{"exercise_price":56.61,"expiration_date":"2031-03-01","underlying":"Common Stock","underlying_shares":63000},"source":{"system":"sec-edgar","filing":"0001209191-23-059929","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919123059929/doc4.xml","form_type":"4"}},{"id":1698744,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & Chair of the Board"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-28T17:29:59.000Z","date":"2023-12-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the effective time of the merger, each outstanding option with an exercise price of $0.40 or more was cancelled effective as of the closing."}],"balance_after":0,"derivative":{"exercise_price":4.61,"expiration_date":"2030-03-30","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001209191-23-059929","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919123059929/doc4.xml","form_type":"4"}},{"id":1698743,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & Chair of the Board"}}],"security":"Common Stock","published_at":"2023-12-28T17:29:59.000Z","date":"2023-12-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":545499,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger dated as of September 21, 2023 (the \"Merger Agreement\"), by and among Cyclo Therapeutics, Inc. (\"Cyclo\"), Cameo Merger Sub, Inc. and the Issuer, each share of Issuer's Common Stock was converted into 0.1331 of a share of Cyclo Common Stock (the \"Transaction Consideration\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Upon consummation of the Merger, the Reporting Person received Transaction Consideration of 72,606 shares of Cyclo common stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-059929","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919123059929/doc4.xml","form_type":"4"}},{"id":1730340,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & Chair of the Board"}}],"security":"Common Stock","published_at":"2023-11-24T16:21:56.000Z","date":"2023-11-22","kind":"sale","planned":false,"acquired":false,"shares":110802,"price":0.1635,"value":18116.127,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs).  This sale satisfies the minimum statutory tax withholding obligations to be funded by a  \"sell-to-cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $0.1634 to $0.164, inclusive.  The reporting person undertakes to provide Applied Molecular Transport, Inc., any security holder of Applied Molecular Transport, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":545499,"source":{"system":"sec-edgar","filing":"0001209191-23-056587","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919123056587/doc4.xml","form_type":"4"}},{"id":1739188,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & Chair of the Board"}}],"security":"Common Stock","published_at":"2023-11-16T17:36:56.000Z","date":"2023-11-15","kind":"sale","planned":false,"acquired":false,"shares":90447,"price":0.1606,"value":14525.7882,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs).  This sale satisfies the minimum statutory tax withholding obligations to be funded by a  \"sell-to-cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $0.15 to $0.1748, inclusive.  The reporting person undertakes to provide Applied Molecular Transport, Inc., any security holder of Applied Molecular Transport, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"A portion of these securities are RSUs.  Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":656301,"source":{"system":"sec-edgar","filing":"0001209191-23-055560","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919123055560/doc4.xml","form_type":"4"}},{"id":1765410,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & Chair of the Board"}}],"security":"Common Stock","published_at":"2023-10-04T19:27:53.000Z","date":"2023-09-05","kind":"sale","planned":false,"acquired":false,"shares":1253,"price":0.2075,"value":259.9975,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs).  This sale satisfies the minimum statutory tax withholding obligations to be funded by a  \"sell-to-cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"A portion of these securities are RSUs.  Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":746748,"source":{"system":"sec-edgar","filing":"0001209191-23-052122","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919123052122/doc4.xml","form_type":"4"}},{"id":1765409,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & Chair of the Board"}}],"security":"Common Stock","published_at":"2023-10-04T19:27:53.000Z","date":"2023-06-02","kind":"sale","planned":false,"acquired":false,"shares":477,"price":0.2402,"value":114.5754,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs).  This sale satisfies the minimum statutory tax withholding obligations to be funded by a  \"sell-to-cover\" transaction and does not represent a discretionary sale by the Reporting Person."}],"balance_after":748001,"source":{"system":"sec-edgar","filing":"0001209191-23-052122","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919123052122/doc4.xml","form_type":"4"}},{"id":1765408,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & Chair of the Board"}}],"security":"Common Stock","published_at":"2023-10-04T19:27:53.000Z","date":"2023-06-02","kind":"sale","planned":false,"acquired":false,"shares":536,"price":0.2404,"value":128.8544,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs).  This sale satisfies the minimum statutory tax withholding obligations to be funded by a  \"sell-to-cover\" transaction and does not represent a discretionary sale by the Reporting Person."}],"balance_after":748478,"source":{"system":"sec-edgar","filing":"0001209191-23-052122","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919123052122/doc4.xml","form_type":"4"}},{"id":1765407,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & Chair of the Board"}}],"security":"Common Stock","published_at":"2023-10-04T19:27:53.000Z","date":"2023-06-02","kind":"sale","planned":false,"acquired":false,"shares":3293,"price":0.2412,"value":794.2716,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs).  This sale satisfies the minimum statutory tax withholding obligations to be funded by a  \"sell-to-cover\" transaction and does not represent a discretionary sale by the Reporting Person."}],"balance_after":749014,"source":{"system":"sec-edgar","filing":"0001209191-23-052122","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919123052122/doc4.xml","form_type":"4"}},{"id":1770547,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & Chair of the Board"}}],"security":"Common Stock","published_at":"2023-10-02T19:02:56.000Z","date":"2023-09-29","kind":"sale","planned":false,"acquired":false,"shares":193960,"price":0.1585,"value":30742.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of RSUs.   This sale satisfies the minimum statutory tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"A portion of these securities are RSUs.  Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":752307,"source":{"system":"sec-edgar","filing":"0001209191-23-051217","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919123051217/doc4.xml","form_type":"4"}},{"id":1770546,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & Chair of the Board"}}],"security":"Common Stock","published_at":"2023-10-02T19:02:56.000Z","date":"2023-09-28","kind":"grant","planned":false,"acquired":true,"shares":886111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUs.  443,055 RSUs vested upon signing of the Agreement and Plan of Merger dated as of September 21, 2023, among Cyclo Therapeutics, Inc., a Nevada corporation, Cameo Merger Sub, Inc., a Delaware corporation and the Issuer (the \"Merger Agreement\").  The remaining 443,056 RSUs vest as to 50% on the date that is five trading days following the filing of the proxy/prospectus relating to stockholder approval of the merger contemplated by the Merger Agreement (the \"Form S-4\") and 50% on the date the Form S-4 is declared effective by the SEC."}],"balance_after":946267,"source":{"system":"sec-edgar","filing":"0001209191-23-051217","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919123051217/doc4.xml","form_type":"4"}},{"id":1937968,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & Chair of the Board"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-27T21:11:02.000Z","date":"2023-03-24","kind":"grant","planned":false,"acquired":true,"shares":668000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/2 of the shares subject to the option shall be vested and exercisable on the date of grant and 1/24 of the remaining shares subject to the option shall vest monthly thereafter, provided that the reporting person remains a service provider to the issuer on each such vest date."}],"balance_after":668000,"derivative":{"exercise_price":0.3936,"expiration_date":"2033-03-23","underlying":"Common Stock","underlying_shares":668000},"source":{"system":"sec-edgar","filing":"0001209191-23-021327","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919123021327/doc4.xml","form_type":"4"}},{"id":1974135,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock","published_at":"2023-03-03T17:20:50.000Z","date":"2023-03-01","kind":"sale","acquired":false,"shares":934,"price":0.5,"value":467.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs).  This sale satisfies the minimum statutory tax withholding obligations to be funded by a  \"sell-to-cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"A portion of these securities are RSUs.  Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":60156,"source":{"system":"sec-edgar","filing":"0001209191-23-015778","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919123015778/doc4.xml","form_type":"4"}},{"id":2094594,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock","published_at":"2022-12-06T16:56:37.000Z","date":"2022-12-02","kind":"sale","acquired":false,"shares":3893,"price":1.0501,"value":4088.0393,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs).  This sale satisfies the minimum statutory tax withholding obligations to be funded by a  \"sell-to-cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"A portion of these securities are RSUs.  Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":61090,"source":{"system":"sec-edgar","filing":"0001209191-22-060031","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919122060031/doc4.xml","form_type":"4"}},{"id":2165790,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock","published_at":"2022-09-06T19:17:03.000Z","date":"2022-09-01","kind":"sale","acquired":false,"shares":416,"price":1.4199,"value":590.6784,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs).  This sale satisfies the minimum statutory tax withholding obligations to be funded by a  \"sell-to-cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"A portion of these securities are RSUs.  Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":64983,"source":{"system":"sec-edgar","filing":"0001209191-22-048870","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919122048870/doc4.xml","form_type":"4"}},{"id":2165789,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock","published_at":"2022-09-06T19:17:03.000Z","date":"2022-09-01","kind":"sale","acquired":false,"shares":468,"price":1.4203,"value":664.7004,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs).  This sale satisfies the minimum statutory tax withholding obligations to be funded by a  \"sell-to-cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"A portion of these securities are RSUs.  Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":65399,"source":{"system":"sec-edgar","filing":"0001209191-22-048870","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919122048870/doc4.xml","form_type":"4"}},{"id":2244983,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock","published_at":"2022-06-03T19:20:05.000Z","date":"2022-06-02","kind":"sale","acquired":false,"shares":2166,"price":3.0425,"value":6590.055,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs).  This sale satisfies the minimum statutory tax withholding obligations to be funded by a  \"sell-to-cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $2.927 to 3.105, inclusive.  The reporting person undertakes to provide Applied Molecular Transport, Inc., any security holder of Applied Molecular Transport, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"A portion of these securities are RSUs.  Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":65867,"source":{"system":"sec-edgar","filing":"0001209191-22-034352","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919122034352/doc4.xml","form_type":"4"}},{"id":2244982,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock","published_at":"2022-06-03T19:20:05.000Z","date":"2022-06-01","kind":"sale","acquired":false,"shares":1767,"price":2.9679,"value":5244.2793,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs).  This sale satisfies the minimum statutory tax withholding obligations to be funded by a  \"sell-to-cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $2.81 to $3.33, inclusive.  The reporting person undertakes to provide Applied Molecular Transport, Inc., any security holder of Applied Molecular Transport, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"A portion of these securities are RSUs.  Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":67983,"source":{"system":"sec-edgar","filing":"0001209191-22-034352","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919122034352/doc4.xml","form_type":"4"}},{"id":2265856,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-18T18:07:34.000Z","date":"2022-05-16","kind":"grant","acquired":true,"shares":84000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48th of the shares subject to the option shall become vested and exercisable on the Exercisable Date set forth above and 1/48th of the shares subject to the option shall continue to vest each month thereafter, provided that Reporting Person is a service provider to the Issuer as of each such vesting date."}],"balance_after":84000,"derivative":{"exercise_price":3.99,"exercise_date":"2022-06-16","expiration_date":"2032-05-16","underlying":"Common Stock","underlying_shares":84000},"source":{"system":"sec-edgar","filing":"0001209191-22-030208","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919122030208/doc4.xml","form_type":"4"}},{"id":2265855,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock","published_at":"2022-05-18T18:07:34.000Z","date":"2022-05-16","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are Restricted Stock Units (RSUs).  Each RSU represents a contingent right to receive one shares of the Issuer's Common Stock.  1/16th of the RSUs shall vest on September 1, 2022 and 1/16th of the RSUs shall vest quarterly thereafter, subject to the Reporting Person continuing as a service provider through each such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"A portion of these securities are RSUs."}],"balance_after":69750,"source":{"system":"sec-edgar","filing":"0001209191-22-030208","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919122030208/doc4.xml","form_type":"4"}},{"id":2392042,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-16T19:57:47.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":94500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the shares subject to the option shall become vested and exercisable on the Exercisable Date set forth above and 1/48th of the shares subject to the option shall continue to vest each month thereafter, provided that Reporting Person is a service provider to the Issuer as of each such vesting date."}],"balance_after":94500,"derivative":{"exercise_price":8.29,"exercise_date":"2022-03-15","expiration_date":"2032-02-15","underlying":"Common Stock","underlying_shares":94500},"source":{"system":"sec-edgar","filing":"0001209191-22-010366","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919122010366/doc4.xml","form_type":"4"}},{"id":2392041,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-16T19:57:47.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":20250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are Restricted Stock Units (RSUs).  Each RSU represents a contingent right to receive one shares of the Issuer's Common Stock.  5/48ths of the RSUs shall vest on June 1, 2022 and 1/16th of the RSUs shall vest quarterly thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":51750,"source":{"system":"sec-edgar","filing":"0001209191-22-010366","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919122010366/doc4.xml","form_type":"4"}},{"id":2441735,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-01-06T19:22:13.000Z","date":"2021-12-24","kind":"grant","acquired":true,"shares":31500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are Restricted Stock Units (RSUs).  Each RSU represents a contingent right to receive one shares of the Issuer's Common Stock.  1/4th of the RSUs shall vest on June 1, 2022 and 1/4th of the RSUs shall vest every six months thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":31500,"source":{"system":"sec-edgar","filing":"0001209191-22-002244","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919122002244/doc4.xml","form_type":"4"}},{"id":2593632,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-23T19:40:40.000Z","date":"2021-08-23","kind":"exercise","acquired":false,"shares":9700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4th of the shares subject to the option became vested on the Exercisable Date and 1/48th of the shares subject to the option vest monthly thereafter, provided that the reporting person is a service provider to the issuer on each such vest date."}],"balance_after":300000,"derivative":{"exercise_price":4.61,"exercise_date":"2021-03-12","expiration_date":"2030-03-20","underlying":"Common Stock","underlying_shares":9700},"source":{"system":"sec-edgar","filing":"0001209191-21-053042","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919121053042/doc4.xml","form_type":"4"}},{"id":2593631,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-23T19:40:40.000Z","date":"2021-08-19","kind":"exercise","acquired":false,"shares":300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4th of the shares subject to the option became vested on the Exercisable Date and 1/48th of the shares subject to the option vest monthly thereafter, provided that the reporting person is a service provider to the issuer on each such vest date."}],"balance_after":309700,"derivative":{"exercise_price":4.61,"exercise_date":"2021-03-12","expiration_date":"2030-03-20","underlying":"Common Stock","underlying_shares":300},"source":{"system":"sec-edgar","filing":"0001209191-21-053042","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919121053042/doc4.xml","form_type":"4"}},{"id":2593630,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-08-23T19:40:40.000Z","date":"2021-08-23","kind":"sale","acquired":false,"shares":9700,"price":30.1227,"value":292190.19,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on April 9, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $30.00 to $30.97, inclusive.  The reporting person undertakes to provide Applied Molecular Transport, Inc., any security holder of Applied Molecular Transport, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-053042","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919121053042/doc4.xml","form_type":"4"}},{"id":2593629,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-08-23T19:40:40.000Z","date":"2021-08-23","kind":"exercise","acquired":true,"shares":9700,"price":4.61,"value":44717.0,"ownership":{"direct":true},"balance_after":9700,"source":{"system":"sec-edgar","filing":"0001209191-21-053042","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919121053042/doc4.xml","form_type":"4"}},{"id":2593628,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-08-23T19:40:40.000Z","date":"2021-08-19","kind":"sale","acquired":false,"shares":300,"price":30.01,"value":9003.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on April 9, 2021."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-053042","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919121053042/doc4.xml","form_type":"4"}},{"id":2593627,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-08-23T19:40:40.000Z","date":"2021-08-19","kind":"exercise","acquired":true,"shares":300,"price":4.61,"value":1383.0,"ownership":{"direct":true},"balance_after":300,"source":{"system":"sec-edgar","filing":"0001209191-21-053042","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919121053042/doc4.xml","form_type":"4"}},{"id":2814320,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":51325,"kind":"person","name":"Cross Shawn","position":1,"cik":"0001734779","reported_name":"Cross Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-03T19:00:28.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":63000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option shall become vested and exercisable on April 1, 2021 and 1/48th of the shares subject to the option shall become vested and exercisable each month thereafter, provided that the reporting person is a service provider to the issuer on each such vest date."}],"balance_after":63000,"derivative":{"exercise_price":56.61,"exercise_date":"2021-04-01","expiration_date":"2031-03-01","underlying":"Common Stock","underlying_shares":63000},"source":{"system":"sec-edgar","filing":"0001209191-21-017310","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919121017310/doc4.xml","form_type":"4"}}]}